导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.59% | 516/2966 |
| 近一周 | 0.01% | 1583/3224 |
| 近一月 | -0.11% | 1763/3231 |
| 近一季 | 0.46% | 668/3202 |
| 近半年 | 0.54% | 728/3126 |
| 近一年 | 1.71% | 604/2939 |
| 近两年 | 6.45% | 854/2422 |
| 近三年 | 12.94% | 203/2059 |
| 成立以来 | 47.53% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-0.04% 959/3040 |
1.15% 813/3451 |
-0.19% 1394/3498 |
- - |
| 2024 | 4.36% 1628/3316 |
1.40% 831/3226 |
1.57% 516/3360 |
-0.19% 2898/3195 |
1.53% 2140/3316 |
| 2023 | 6.10% 145/3108 |
2.17% 159/2776 |
1.34% 775/2849 |
1.04% 186/2940 |
1.41% 230/3108 |
| 2022 | 2.75% 560/2726 |
0.64% 537/1949 |
1.74% 90/2522 |
1.64% 137/2598 |
-1.27% 2292/2732 |
| 2021 | 3.89% 1172/2409 |
1.16% 231/2068 |
1.90% 110/2668 |
1.81% 297/2731 |
-1.01% 2277/2416 |
| 2020 | -2.42% 1679/2196 |
1.91% 875/1576 |
0.30% 239/2274 |
0.75% 246/2475 |
-5.25% 2447/2563 |
| 2019 | 2.60% 1152/1720 |
0.87% 1276/1682 |
-0.20% 1332/1824 |
1.19% 716/1762 |
0.71% 1496/1956 |
| 2018 | 6.84% 409/1267 |
- - |
- - |
- - |
1.81% 486/1543 |
| 2017 | -0.27% 654/1017 |
- - |
- - |
- - |
- - |
| 2016 | 0.77% 245/769 |
- - |
- - |
- - |
- - |
| 2015 | 10.97% 131/377 |
- - |
- - |
- - |
- - |
| 2014 | 5.42% 240/251 |
- - |
- - |
- - |
- - |
| 2013 | -2.69% 74/87 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 国投瑞银白银期货(LOF)A | 1.7164 | 48.92% |
| 国投瑞银白银期货(LOF)C | 1.7017 | 48.76% |
| 泰信现代服务业混合 | 2.1670 | 38.91% |
| 创金合信全球医药生物股票发起(QDII)C | 1.7789 | 37.65% |
| 泰信发展主题混合 | 1.8890 | 37.48% |
| 永赢先锋半导体智选混合发起A | 1.2881 | 28.89% |
| 永赢先锋半导体智选混合发起C | 1.2863 | 28.72% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 嘉实资源精选股票A | 4.7401 | 21.68% |
| 华商致远回报混合C | 1.6720 | 21.39% |
| 工银信用纯债债券B VS. () |